Primary |
Ill-defined Disorder |
17.4% |
Anxiety |
11.4% |
Depression |
7.4% |
Drug Use For Unknown Indication |
6.4% |
Premedication |
6.2% |
Pruritus |
6.2% |
Product Used For Unknown Indication |
5.9% |
Insomnia |
4.8% |
Urticaria |
4.8% |
Hypertension |
3.9% |
Psychotic Disorder |
3.8% |
Pain |
3.3% |
Anaesthesia |
2.8% |
Abnormal Behaviour |
2.6% |
Dermatitis Atopic |
2.5% |
General Anaesthesia |
2.4% |
Preoperative Care |
2.2% |
Bipolar Disorder |
2.1% |
Sleep Disorder |
2.0% |
Abdominal Pain |
1.8% |
|
Suicide Attempt |
17.3% |
Injection Site Ulcer |
8.7% |
Somnolence |
8.0% |
Toxic Skin Eruption |
6.6% |
Tremor |
6.2% |
Injection Site Necrosis |
5.9% |
Vomiting |
5.5% |
Tachycardia |
4.5% |
Respiratory Depression |
4.2% |
Urinary Retention |
4.2% |
Pruritus |
3.5% |
Skin Necrosis |
3.5% |
Thrombocytopenia |
3.5% |
Drug Rash With Eosinophilia And Systemic Symptoms |
3.1% |
Angioedema |
2.8% |
Hepatic Function Abnormal |
2.8% |
Urticaria |
2.8% |
Rash |
2.4% |
Transaminases Increased |
2.4% |
Urinary Tract Infection |
2.4% |
|
Secondary |
Product Used For Unknown Indication |
36.0% |
Drug Use For Unknown Indication |
22.4% |
Depression |
5.6% |
Anxiety |
5.6% |
Insomnia |
3.8% |
Hypertension |
2.7% |
Pruritus |
2.7% |
Premedication |
2.7% |
Drug Exposure During Pregnancy |
2.5% |
Pain |
2.4% |
Ill-defined Disorder |
2.2% |
Agitation |
1.7% |
Myocardial Ischaemia |
1.5% |
Psychotic Disorder |
1.3% |
Pyrexia |
1.2% |
Induction Of Anaesthesia |
1.2% |
Prophylaxis |
1.2% |
Infection |
1.1% |
Type 2 Diabetes Mellitus |
1.1% |
Hypothyroidism |
1.0% |
|
Toxic Skin Eruption |
11.7% |
Suicide Attempt |
8.5% |
Tachycardia |
8.3% |
Renal Failure Acute |
7.3% |
Thrombocytopenia |
7.0% |
Drug Rash With Eosinophilia And Systemic Symptoms |
5.7% |
Urinary Retention |
5.4% |
Toxic Epidermal Necrolysis |
4.9% |
Stevens-johnson Syndrome |
4.7% |
Vomiting |
4.4% |
Electrocardiogram Qt Prolonged |
4.1% |
Tremor |
3.9% |
Somnolence |
3.4% |
Rash |
3.1% |
Renal Failure |
3.1% |
Sepsis |
3.1% |
Urticaria |
3.1% |
Hypoglycaemia |
2.8% |
Vertigo |
2.8% |
Confusional State |
2.6% |
|
Concomitant |
Product Used For Unknown Indication |
22.2% |
Drug Use For Unknown Indication |
17.3% |
Prophylaxis |
7.6% |
Hypertension |
5.5% |
Pain |
5.3% |
Insomnia |
4.5% |
Depression |
4.4% |
Anxiety |
3.8% |
Hepatitis C |
3.2% |
Infection |
3.1% |
Pruritus |
2.8% |
Sedation |
2.8% |
Fluid Replacement |
2.6% |
Ureteral Stent Insertion |
2.5% |
Ureteral Stent Removal |
2.5% |
Premedication |
2.5% |
Constipation |
1.9% |
Hiv Infection |
1.9% |
Psoriasis |
1.8% |
Infection Prophylaxis |
1.8% |
|
Vomiting |
11.6% |
White Blood Cell Count Decreased |
8.2% |
Pyrexia |
7.6% |
Weight Increased |
7.2% |
Weight Decreased |
7.1% |
Respiratory Failure |
6.3% |
Rash |
5.8% |
Renal Failure Acute |
5.5% |
Thrombocytopenia |
5.0% |
Renal Failure |
4.3% |
Urticaria |
3.5% |
Pulmonary Embolism |
3.4% |
Urinary Tract Infection |
3.3% |
Tachycardia |
3.2% |
Tremor |
3.2% |
Toxic Skin Eruption |
3.1% |
Vision Blurred |
3.1% |
Death |
3.0% |
Neutropenia |
2.9% |
White Blood Cell Count Increased |
2.9% |
|
Interacting |
Anxiety |
11.2% |
Drug Use For Unknown Indication |
11.2% |
Insomnia |
8.6% |
Myocardial Infarction |
8.6% |
Agitation |
6.9% |
Dementia |
6.9% |
Depression |
6.9% |
Bipolar Disorder |
5.2% |
Urticaria Chronic |
5.2% |
Hallucination |
4.3% |
Emphysema |
3.4% |
Psychotic Disorder |
3.4% |
Abdominal Pain |
2.6% |
Hypertension |
2.6% |
Intervertebral Disc Protrusion |
2.6% |
Nausea |
2.6% |
Sedation |
2.6% |
Abnormal Behaviour |
1.7% |
Atrial Fibrillation |
1.7% |
Heart Rate Increased |
1.7% |
|
Drug Interaction |
12.9% |
Somnolence |
12.9% |
Extrapyramidal Disorder |
9.7% |
Rhabdomyolysis |
9.7% |
Coma |
6.5% |
Fall |
6.5% |
Myoclonus |
6.5% |
Tremor |
6.5% |
White Blood Cell Disorder |
6.5% |
Wrong Drug Administered |
6.5% |
Blood Pressure Fluctuation |
3.2% |
Disorientation |
3.2% |
Femoral Neck Fracture |
3.2% |
Hyperkalaemia |
3.2% |
Sedation |
3.2% |
|